Track Orphazyme A/S's net tangible assets ($16M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2024), ORPHY shows a net tangible assets of $16M. That compares with $29M in the prior-year period — down 44.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ORPHY's net tangible assets is now $16M (was $29M) — a 44.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.
Tracking ORPHY's net tangible assets over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $29M in the prior-year period — down 44.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net tangible assets page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $16M) with ownership activity and broader fundamentals.
Orphazyme A/S's net tangible assets is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.